• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biocon Limited — Updates, 21-04-2026: Press Release

    21-04-2026 | 08:48 am

    Biocon received Health Canada approval for two denosumab biosimilars, Bosaya™ and Vevzuo™. This expands their portfolio, offering affordable biologic therapies in Canada for osteoporosis and cancer-related bone conditions, boosting market access.

    No comments yet. Be the first to comment!

    All announcements from Biocon Limited